norethindrone acetate has been researched along with Benign Neoplasms in 4 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hazard ratio for deep vein thrombosis (2 in treated group v 1 in control group) was 2." | 2.77 | Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. ( Eiken, P; Jensen, JE; Køber, L; Mosekilde, L; Rejnmark, L; Schierbeck, LL; Stilgren, L; Tofteng, CL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Schierbeck, LL | 1 |
| Rejnmark, L | 1 |
| Tofteng, CL | 1 |
| Stilgren, L | 1 |
| Eiken, P | 1 |
| Mosekilde, L | 1 |
| Køber, L | 1 |
| Jensen, JE | 1 |
| BRISCOE, CC | 1 |
| Maier, WE | 1 |
| Herman, JR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Danish Osteoporosis Prevention Study[NCT00252408] | Phase 4 | 2,000 participants | Interventional | 1990-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for norethindrone acetate and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals.
Topics: Animals; Animals, Laboratory; Contraceptives, Oral; Dogs; Dose-Response Relationship, Drug; Drug Com | 2001 |
1 trial available for norethindrone acetate and Benign Neoplasms
| Article | Year |
|---|---|
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
Topics: Breast Neoplasms; Contraceptives, Oral, Synthetic; Denmark; Estradiol; Estrogens; Female; Follicle S | 2012 |
1 other study available for norethindrone acetate and Benign Neoplasms
| Article | Year |
|---|---|
ACUTE HEMORRHAGIC DEGENERATION OF A LEIOMYOMA FOLLOWING NORETHINDRONE ACETATE: REPORT OF A CASE.
Topics: Female; Humans; Leiomyoma; Neoplasms; Norethindrone; Norethindrone Acetate; Pathology; Surgical Proc | 1964 |